UNEARTH RX Trademark

Trademark Overview


On Monday, February 5, 2024, a trademark application was filed for UNEARTH RX with the United States Patent and Trademark Office. The USPTO has given the UNEARTH RX trademark a serial number of 98391202. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Wednesday, August 28, 2024. This trademark is owned by Kapoose Creek Bio Corp.. The UNEARTH RX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biochemical research and analysis; biomedical research; chemical analysis; chemical research; consulting services in the field of pharmaceutical research; drug discovery services; drug screening for scientific research purposes; executing of chemical analyses; industrial analysis and research services in the field of agriculture and horticulture; medical research; pharmacological research services; research and analysis in the field of medicine; research and design in the field of chemistry; research and development of new products for others; research and development of vaccines and medicines; research in the field of artificial intelligence technology; research in the field of biochemistry; testing of new products for others; medical and pharmaceutical research and development services in the field of mycology; medical and pharmaceutical research and development services utilizing artificial intelligence and machine learning; medical and pharmaceutical research and development servic...
unearth rx

General Information


Serial Number98391202
Word MarkUNEARTH RX
Filing DateMonday, February 5, 2024
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateWednesday, August 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBiochemical research and analysis; biomedical research; chemical analysis; chemical research; consulting services in the field of pharmaceutical research; drug discovery services; drug screening for scientific research purposes; executing of chemical analyses; industrial analysis and research services in the field of agriculture and horticulture; medical research; pharmacological research services; research and analysis in the field of medicine; research and design in the field of chemistry; research and development of new products for others; research and development of vaccines and medicines; research in the field of artificial intelligence technology; research in the field of biochemistry; testing of new products for others; medical and pharmaceutical research and development services in the field of mycology; medical and pharmaceutical research and development services utilizing artificial intelligence and machine learning; medical and pharmaceutical research and development services utilizing phenotypic screening; phenotypic screening analysis in the field of mycology drug discovery services utilizing artificial intelligence and machine learning; providing non-downloadable software for recommending chemical compounds based on artificial intelligence and machine learning; medical and pharmaceutical research and development services utilizing artificial intelligence and machine learning

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 5, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKapoose Creek Bio Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver, BC V6H3Y4
CA

Trademark Events


Event DateEvent Description
Monday, February 5, 2024NEW APPLICATION ENTERED
Sunday, June 2, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 28, 2024ASSIGNED TO EXAMINER